Literature DB >> 9420220

Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells.

J Wu1, J O'Neill, M S Barbosa.   

Abstract

Human cytomegalovirus (HCMV) gene expression is highly cell and tissue specific. Cell factor-mediated regulatory interactions are involved in regulating the restricted expression of the HCMV major immediate-early (IE) gene (J. F. Baskar, P. P. Smith, G. Nilaver, R. A. Jupp, S. Hoffmann, N. J. Peffer, D. J. Tenney, A. M. Colberg-Poley, P. Ghazal, and J. A. Nelson, 70:3207-3213, 1996). To gain an understanding of HCMV early gene activation, we studied the effect of each of the three major IE proteins, IE72, IE86, and IE55, on the HCMV DNA polymerase gene (pol; UL54) promoter. In transient-expression assays, the IE86 protein alone was able to transactivate the pol promoter, but IE72 and IE55 were not, in permissive U373MG cells. However, we were unable to detect IE86-mediated transactivation in nonpermissive HeLa or C33-A cells. Using electrophoretic mobility shift assays (EMSAs), we found that expression of the IE86 protein in U373MG cells resulted in specific binding of a DNA complex to an inverted-repeat element, IR1, of the pol promoter. Antibody supershifting and EMSA-Western blotting experiments further showed that IE86 and the cellular transcription factor Sp1 were components of the IR1 DNA-binding complex. Furthermore, we found that binding of DNA by Sp1 was dramatically increased in the presence of IE86. Interestingly, this IE86-induced DNA-binding activity of Sp1 was inhibited by a repressor activity presented in HeLa cells. In summary, our study suggests that a viral regulatory protein can modulate the DNA binding activity of a cellular transcription factor, resulting in cell-specific transactivation of viral genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420220      PMCID: PMC109369     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Negative and positive regulation by a short segment in the 5'-flanking region of the human cytomegalovirus major immediate-early gene.

Authors:  J A Nelson; C Reynolds-Kohler; B A Smith
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

2.  The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Authors:  J A Kerry; M A Priddy; T L Staley; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

4.  The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.

Authors:  J F Baskar; P P Smith; G Nilaver; R A Jupp; S Hoffmann; N J Peffer; D J Tenney; A M Colberg-Poley; P Ghazal; J A Nelson
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  A novel mechanism for persistence of human cytomegalovirus in macrophages.

Authors:  K N Fish; W Britt; J A Nelson
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter.

Authors:  L Huang; M F Stinski
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

7.  Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.

Authors:  A D Yurochko; M W Mayo; E E Poma; A S Baldwin; E S Huang
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter.

Authors:  P Luu; O Flores
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection.

Authors:  J A Kerry; M A Priddy; T Y Jervey; C P Kohler; T L Staley; C D Vanson; T R Jones; A C Iskenderian; D G Anders; R M Stenberg
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins.

Authors:  B Detrick; J Rhame; Y Wang; C N Nagineni; J J Hooks
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-04       Impact factor: 4.799

View more
  14 in total

1.  Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression.

Authors:  Jiping Chen; Mark F Stinski
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element.

Authors:  J Chen; M F Stinski
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Giulia Muratore; Serena Massari; Maria Elena Terlizzi; Oriana Tabarrini; Giorgio Gribaudo; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 4.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

5.  Novel immediate-early protein IE19 of human cytomegalovirus activates the origin recognition complex I promoter in a cooperative manner with IE72.

Authors:  Masaki Shirakata; Masakazu Terauchi; Melike Ablikim; Ken-Ichi Imadome; Kanji Hirai; Takeshi Aso; Yuji Yamanashi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes.

Authors:  A Marchini; H Liu; H Zhu
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression.

Authors:  J J García-Ramírez; F Ruchti; H Huang; K Simmen; A Angulo; P Ghazal
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.

Authors:  Arianna Loregian; Beatrice Mercorelli; Giulia Muratore; Elisa Sinigalia; Silvana Pagni; Serena Massari; Giorgio Gribaudo; Barbara Gatto; Manlio Palumbo; Oriana Tabarrini; Violetta Cecchetti; Giorgio Palù
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

9.  NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.

Authors:  Emma Poole; Elizabeth Atkins; Takashi Nakayama; Osamu Yoshie; Ian Groves; Antonio Alcami; John Sinclair
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

10.  Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.

Authors:  Rebecca L Sanders; Charles L Clark; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.